trending Market Intelligence /marketintelligence/en/news-insights/trending/C8WCXqlbKrWrS_fwtNo7uw2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

US FDA approves Lupin's generic dermatosis ointment

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


US FDA approves Lupin's generic dermatosis ointment

Lupin Ltd. received final approval from the U.S. FDA to market its desoximetasone ointment USP, 0.05%, a generic equivalent of Taro Pharmaceutical Industries Ltd.'s Topicort Ointment.

The ointment is for the relief of inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.